Effectiveness and safety of eravacycline-based regimens for resistant Acinetobacter baumannii infections: a systematic review and meta-analysis

医学 鲍曼不动杆菌 重症监护医学 梅德林 抗生素 抗生素耐药性 临床试验 大流行 不利影响 系统回顾
作者
Shahd Mohammad,Eman Awwad,Ayah Hajjar,Sulaiman Alzunaydi,Ahmed AK Al-Hammadi,Thamer A. Almangour,M Bassetti
出处
期刊:Expert Review of Anti-infective Therapy [Taylor & Francis]
卷期号:24 (9): 855-865
标识
DOI:10.1080/14787210.2026.2699179
摘要

INTRODUCTION Acinetobacter baumannii, particularly multidrug-resistant strains, is a high-burden nosocomial pathogen with limited therapeutic options. Eravacycline is increasingly used off-label despite limited supporting clinical evidence. This meta-analysis aimed to evaluate the effectiveness and safety of eravacycline versus non – eravacycline-based regimens in adults with resistant A. baumannii infections.METHODS MEDLINE, Embase, and Cochrane Central were searched for studies evaluating eravacycline regimens in hospitalized adults with A. baumannii infection. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models. Data were analyzed using R statistical software.RESULTS Fifteen studies encompassing 462 patients were included. Populations consisted predominantly of older adults, with respiratory tract infections representing the most common source of infection (77.6%). Carbapenem-resistant A. baumannii accounted for 84.4% of evaluable cases. No statistically significant differences were observed between eravacycline and non – eravacycline-based regimens in all-cause mortality (RR 1.06; 95% CI 0.46–2.47), clinical cure (RR 0.90; 95% CI 0.77–1.07), or microbiological eradication (RR 0.88; 95% CI 0.56–1.37). Complementary single-arm pooled estimates among eravacycline-treated cohorts were favorable.CONCLUSION This meta-analysis strengthens the evidence base for eravacycline effectiveness in resistant A. baumannii infections and supports its consideration when preferred regimens are not feasible; adequately powered randomized trials are needed to define optimal positioning.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
暴躁的棉花糖完成签到,获得积分10
1秒前
2秒前
土豆完成签到,获得积分10
3秒前
3秒前
nihao发布了新的文献求助10
4秒前
哈哈哈完成签到 ,获得积分10
4秒前
海鹏发布了新的文献求助10
5秒前
51515发布了新的文献求助10
5秒前
6秒前
7秒前
7秒前
8秒前
8秒前
ding的应助被学医不如捡垃圾采纳,获得10
8秒前
Ai发布了新的文献求助20
9秒前
ding的应助被嘎嘎的鸡神采纳,获得10
9秒前
ethyxwat发布了新的文献求助10
9秒前
10秒前
nihao完成签到,获得积分10
10秒前
任性山芙发布了新的文献求助10
10秒前
车里子发布了新的文献求助10
10秒前
Owen的应助被西出阳关采纳,获得10
10秒前
11秒前
jiaaniu完成签到 ,获得积分10
11秒前
ltt关闭了ltt的文献求助
12秒前
12秒前
传奇3的应助被科研通管家采纳,获得10
12秒前
炙热从蕾发布了新的文献求助10
12秒前
顾矜的应助被科研通管家采纳,获得30
12秒前
orixero的应助被科研通管家采纳,获得10
13秒前
13秒前
DW的应助被科研通管家采纳,获得10
13秒前
bkagyin的应助被科研通管家采纳,获得10
13秒前
小蘑菇的应助被科研通管家采纳,获得10
13秒前
慕青的应助被科研通管家采纳,获得30
13秒前
大个的应助被科研通管家采纳,获得10
13秒前
orixero的应助被科研通管家采纳,获得10
13秒前
SciGPT的应助被科研通管家采纳,获得10
13秒前
ashley完成签到,获得积分10
14秒前
Jasper的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178617
求助须知:如何正确求助?哪些是违规求助? 9569413
关于积分的说明 21804370
捐赠科研通 7773649
什么是DOI,文献DOI怎么找? 3432878
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478478